diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM]
- RxCUI
- 1550963
- RxNorm name
- diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM]
- Display name
- ALEVE PM (Oral Pill)
- Full name
- diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM]
- Term type
- SBD
- Status
- Active
- Strength
- 25-220 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-13 14:25:15
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112014
- Active start
- 112014
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| diphenhydramine hydrochloride | 25 MG / 1 EACH | diphenhydramine | diphenhydramine hydrochloride |
| naproxen sodium | 220 MG / 1 EACH | naproxen | naproxen sodium |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| diphenhydramine | 3498 |
| naproxen | 7258 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Aleve PM (diphenhydrAMINE hydrochloride 25 MG / naproxen sodium 220 MG) Oral Tablet | 1 | NAMES |
| RxNorm Name | diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM] | 1 | NAMES |
| RxNorm Synonym | Aleve PM (diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG) Oral Tablet | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 82891458-ab0d-459a-8602-dcebd22c3010 | 1 | CODES |
| RxCUI | 1550963 | 1 | CODES |
| MMSL_CODE | BD30191 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0280-1200-01 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-02 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-03 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-04 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-05 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-08 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-20 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-40 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
| 0280-1200-80 | 0280-1200 | Aleve PM DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM | Bayer HealthCare LLC. | NDA205352 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aleve PM | DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM | Bayer HealthCare LLC. | 82891458-ab0d-459a-8602-dcebd22c3010 | 2025-12-04 | Warnings | 0280-1200-02 0280-1200-04 0280-1200-05 0280-1200-03 0280-1200-80 0280-1200-08 0280-1200-20 0280-1200-01 0280-1200-40 0280-1200 00280120001 00280120005 00280120080 00280120004 00280120002 00280120008 00280120020 00280120003 00280120040 1550963 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 82891458-ab0d-459a-8602-dcebd22c3010 | Aleve PM 25 MG / 220 MG Oral Tablet [PSN] · diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM] [SBD] · Aleve PM (diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG) Oral Tablet [SY] | 3 | 16 | Aleve ® PM | 20251204 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 82891458-ab0d-459a-8602-dcebd22c3010 | Aleve ® PM | Bayer HealthCare LLC. | 20251204 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R06AA | Aminoalkyl ethers | ATC1-4 | diphenhydramine | |
| ATC | D04AA | Antihistamines for topical use | ATC1-4 | diphenhydramine | |
| ATC | M02AA | Antiinflammatory preparations, non-steroids for topical use | ATC1-4 | naproxen | |
| ATC | G02CC | Antiinflammatory products for vaginal administration | ATC1-4 | naproxen | |
| ATC | M01AE | Propionic acid derivatives | ATC1-4 | diphenhydramine / naproxen | |
| ATC | M01AE | Propionic acid derivatives | ATC1-4 | naproxen | |
| FDASPL | N0000175587 | Histamine-1 Receptor Antagonist | EPC | has_epc | diphenhydramine |
| FDASPL | N0000175722 | Nonsteroidal Anti-inflammatory Drug | EPC | has_epc | naproxen |
| FDASPL | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | naproxen |
| FDASPL | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | diphenhydramine |
| MEDRT | D004155 | Diphenhydramine | CHEM | has_ingredient | diphenhydramine hydrochloride |
| MEDRT | D004155 | Diphenhydramine | CHEM | has_ingredient | diphenhydramine |
| MEDRT | D009288 | Naproxen | CHEM | has_ingredient | naproxen |
| MEDRT | D009288 | Naproxen | CHEM | has_ingredient | naproxen sodium |
| MEDRT | D001008 | Anxiety Disorders | DISEASE | may_treat | diphenhydramine |
| MEDRT | D001008 | Anxiety Disorders | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | D001171 | Arthritis, Juvenile | DISEASE | may_treat | naproxen |
| MEDRT | D001171 | Arthritis, Juvenile | DISEASE | may_treat | naproxen sodium |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | naproxen sodium |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | naproxen |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | naproxen sodium |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | naproxen |
| MEDRT | D002062 | Bursitis | DISEASE | may_treat | naproxen |
| MEDRT | D002062 | Bursitis | DISEASE | may_treat | naproxen sodium |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | naproxen sodium |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | naproxen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | diphenhydramine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naproxen sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naproxen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | diphenhydramine |
| MEDRT | D004412 | Dysmenorrhea | DISEASE | may_treat | naproxen sodium |
| MEDRT | D004412 | Dysmenorrhea | DISEASE | may_treat | naproxen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | naproxen sodium |
| MEDRT | D005334 | Fever | DISEASE | may_treat | naproxen |
| MEDRT | D006073 | Gout | DISEASE | may_treat | naproxen sodium |
| MEDRT | D006073 | Gout | DISEASE | may_treat | naproxen |
| MEDRT | D006261 | Headache | DISEASE | may_treat | naproxen |
| MEDRT | D006261 | Headache | DISEASE | may_treat | naproxen sodium |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | diphenhydramine |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | diphenhydramine hydrochloride |
| MEDRT | D007234 | Infant, Premature | DISEASE | ci_with | diphenhydramine hydrochloride |
| MEDRT | D007234 | Infant, Premature | DISEASE | ci_with | diphenhydramine |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | naproxen |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | naproxen sodium |
| MEDRT | D007774 | Lactation | DISEASE | ci_with | diphenhydramine hydrochloride |
| MEDRT | D007774 | Lactation | DISEASE | ci_with | diphenhydramine |
| MEDRT | D009041 | Motion Sickness | DISEASE | may_treat | diphenhydramine |
| MEDRT | D009041 | Motion Sickness | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | D009325 | Nausea | DISEASE | may_treat | diphenhydramine |
| MEDRT | D009325 | Nausea | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | naproxen sodium |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | naproxen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | naproxen sodium |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | naproxen |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | naproxen |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | naproxen sodium |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | diphenhydramine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | D007319 | Sleep Initiation and Maintenance Disorders | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | D007319 | Sleep Initiation and Maintenance Disorders | DISEASE | may_treat | diphenhydramine |
| MEDRT | D012912 | Sneezing | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | D012912 | Sneezing | DISEASE | may_treat | diphenhydramine |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | naproxen |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | naproxen sodium |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | ci_with | diphenhydramine hydrochloride |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | ci_with | diphenhydramine |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | naproxen |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | naproxen sodium |
| MEDRT | D014581 | Urticaria | DISEASE | may_treat | diphenhydramine |
| MEDRT | D014581 | Urticaria | DISEASE | may_treat | diphenhydramine hydrochloride |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | naproxen sodium |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | naproxen |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | diphenhydramine |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | diphenhydramine hydrochloride |
| MEDRT | N0000008831 | Decreased Platelet Activating Factor Production | PE | has_pe | naproxen sodium |
| MEDRT | N0000008831 | Decreased Platelet Activating Factor Production | PE | has_pe | naproxen |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | naproxen sodium |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | naproxen |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | naproxen sodium |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | naproxen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | naproxen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | naproxen sodium |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 25 MG / 220 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA205352 |
| NAMES | Prescribable Synonym | Aleve PM 25 MG / 220 MG Oral Tablet |
| NAMES | Tallman Synonym | Aleve PM (diphenhydrAMINE hydrochloride 25 MG / naproxen sodium 220 MG) Oral Tablet |
| NAMES | Tallman Synonym | diphenhydrAMINE hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |